Lynk Pharmaceuticals Announces Clinical Approval in China for Its Class I New Drug LNK01004

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

China ,Hangzhou ,Zhejiang , ,Pfizer ,Prnewswire Lynk Pharmaceuticals Co Ltd ,Lynk Pharmaceuticals ,National Medical Products Administration ,Johnson ,Business ,Health ,Pr Newswire ,Clinical Trials ,Psoriasis ,